GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atreca Inc (FRA:0C1) » Definitions » EV-to-EBITDA

Atreca (FRA:0C1) EV-to-EBITDA : 0.24 (As of May. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Atreca EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Atreca's enterprise value is €-15.67 Mil. Atreca's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was €-65.97 Mil. Therefore, Atreca's EV-to-EBITDA for today is 0.24.

The historical rank and industry rank for Atreca's EV-to-EBITDA or its related term are showing as below:

FRA:0C1' s EV-to-EBITDA Range Over the Past 10 Years
Min: -2.39   Med: 0   Max: 1.25
Current: 0.24

During the past 6 years, the highest EV-to-EBITDA of Atreca was 1.25. The lowest was -2.39. And the median was 0.00.

FRA:0C1's EV-to-EBITDA is ranked better than
88.91% of 451 companies
in the Biotechnology industry
Industry Median: 9.67 vs FRA:0C1: 0.24

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), Atreca's stock price is €0.0435. Atreca's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was €-2.337. Therefore, Atreca's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Atreca EV-to-EBITDA Historical Data

The historical data trend for Atreca's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atreca EV-to-EBITDA Chart

Atreca Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial - -3.95 -4.22 0.03 -0.27

Atreca Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.40 -0.27 -0.60 -0.80 0.14

Competitive Comparison of Atreca's EV-to-EBITDA

For the Biotechnology subindustry, Atreca's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atreca's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atreca's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Atreca's EV-to-EBITDA falls into.



Atreca EV-to-EBITDA Calculation

Atreca's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=-15.665/-65.966
=0.24

Atreca's current Enterprise Value is €-15.67 Mil.
Atreca's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-65.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Atreca  (FRA:0C1) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Atreca's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0435/-2.337
=At Loss

Atreca's share price for today is €0.0435.
Atreca's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.337.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Atreca EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Atreca's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Atreca (FRA:0C1) Business Description

Traded in Other Exchanges
Address
835 Industrial Road, Suite 400, San Carlos, CA, USA, 94070
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. It has single segment business of therapeutic drug discovery and development. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Atreca (FRA:0C1) Headlines

No Headlines